FindTrial
Sign In

Analysis of the Effectiveness of the Anti-motion Sickness Glasses for Reading in Vehicles

Validation of Antikinetosis Sickness Glasses for Reading in Vehicles

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3n7pzqt
Enrollment
Unknown
Registered
2023-08-17
Start date
2022-08-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motion sickness

Interventions

This is a controlled randomized crossover clinical study with two intervention arms. It was a single-blind study that compared the effects of anti-motion sickness glasses during reading in moving vehi
E07.632.500.300

Sponsors

APEC - Sociedade Potiguar de Educação e Cultura S.A
Lead Sponsor
Liga Norte Riograndense Contra o Câncer
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Being a student at the Universidade Potiguar; having signs or symptoms of motion sickness while reading in vehicles; not being under the use of antikinetosis medication; be at least 18 years old.

Exclusion criteria

Exclusion criteria: The exclusion criterion is not meeting all the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
To evaluate the effectiveness of antikinetosis glasses in individuals affected by this condition, while reading in vehicles, under controlled conditions.—

Secondary

MeasureTime frame
No secondary outcomes are expected.—

Countries

Brazil

Contacts

Public ContactFrancisco Pinheiro

Universidade Potiguar

irochima@gmail.com+5508432154247

Outcome results

None listed

Source: REBEC (via WHO ICTRP)